Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J. Nelson, Christopher B. Granger, Jennifer B. Green et al.|Circulation|2021Cited by 79
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J. Nelson, Christopher B. Granger, Emily C. O’Brien et al.|JAMA Network Open|2022Cited by 73